Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Rhea-AI Summary

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) will report its first quarter 2024 financial results on May 8, 2024. The company focuses on unmet needs in eye care. A live webcast will be held to provide the results and a corporate update.

IRVINE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that it will host a live webcast at 1.30 p.m. PT / 4.30 p.m. ET on Wednesday, May 8, 2024 to report its first quarter 2024 financial results and provide a corporate update.

Participants may access the webcast here. A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for at least 90 days.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology and infectious disease prevention. XDEMVY^® (lotilaner ophthalmic solution) 0.25% is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-03 as an investigational therapy for the treatment of Meibomian Gland Disease, TP-04 for the treatment of rosacea and TP-05 as an oral tablet for the prevention of Lyme disease, all of which are in Phase 2.

Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
akemp@tarsusrx.com

Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com

FAQ

When will Tarsus Pharmaceuticals report its first quarter 2024 financial results?

Tarsus Pharmaceuticals will report its first quarter 2024 financial results on Wednesday, May 8, 2024.

What is the stock symbol for Tarsus Pharmaceuticals?

The stock symbol for Tarsus Pharmaceuticals is NASDAQ: TARS.

What is the focus area of Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals focuses on unmet needs, starting with eye care.

How can participants access the webcast of the financial results?

Participants can access the live webcast at 1.30 p.m. PT / 4.30 p.m. ET on Wednesday, May 8, 2024.

Will there be a recorded version of the financial results call available?

Yes, a recorded version of the call will be available on the website shortly after the webcast and will be archived for at least 90 days.